Skip to main content
Equibles

OSAIC HOLDINGS, INC.

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 1677044 SCOTTSDALE, AZ
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$889,791
+$689,831 QoQ
Shares Held
60,284
+27.5% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 192 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

OSAIC HOLDINGS, INC. holds $240,097,471 across 405 Biotechnology names. SLS ranks #39 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LGND
Ligand Pharmaceuticals Inc
 90,236 $28,522,697
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 49,586 $24,630,851
3 TGTX
Tg Therapeutics, Inc.
 372,588 $20,469,983
4 BBIO
BridgeBio Pharma, Inc.
 217,577 $16,205,134
5 HALO
Halozyme Therapeutics, Inc.
 176,973 $13,851,674
6 ALNY
Alnylam Pharmaceuticals, Inc.
 45,298 $13,636,055
7 VCEL
Vericel Corp
 182,038 $8,098,869
8 REGN
Regeneron Pharmaceuticals, Inc.
 12,423 $7,746,234

All Filings in SLS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $889,791 60,284
2026-03-31 $199,960 47,272
2025-12-31 $89,307 23,689
2025-09-30 $12,332 7,660
2025-06-30 $16,775 7,660
2025-03-31 $2,872 2,660
2024-12-31 $1,726 1,660
2024-09-30 $2,075 1,660
2024-06-30 $1,975 1,660
2024-03-31 $1,676 1,660
2023-12-31 $1,759 1,660
2023-09-30 $5,444 3,320
2023-06-30 $2,606 1,660
2023-03-31 $2,373 1,660
2022-12-31 $3,917 1,660
2022-09-30 $3,363 1,665
2022-06-30 $4,158 1,865
2022-03-31 $5,777 865
2021-12-31 $4,782 865
2021-09-30 $19,051 2,080
2021-06-30 $17,537 1,580
2021-03-31 $11,742 1,375
2020-12-31 $1,800 310
2020-09-30 $424 160
2020-06-30 $468 160
2020-03-31 $276 160